This content was funded by Bacteromic Sp. z o.o.
Antimicrobial resistance (AMR) represents one of the most pressing threats to global health, with projections suggesting it could claim 10 million lives annually by 2050. This webinar brings together two leading experts to examine the current AMR landscape and explore how rapid diagnostic technologies are transforming clinical decision-making and patient outcomes.
Topics Covered
- The global burden of AMR, including key resistant pathogens (carbapenem-resistant Klebsiella pneumoniae, MRSA, VRE) and regional trends across Europe
- Drivers of resistance, including antibiotic overuse, environmental contamination, and nosocomial transmission
- The role of rapid antimicrobial susceptibility testing (AST) in enabling timely de-escalation or escalation of therapy
- Barriers to adoption of new diagnostic technologies, including cost, workflow integration, staffing, and clinician confidence
- How laboratories and clinicians can shift the perception of susceptibility testing from a regulatory formality to an essential patient safety tool
Speakers
Alberto Antonelli
Mirela Flonta
- Tenure track Researcher, University of Florence, Italy; Clinical Microbiologist, Careggi University Hospital, Florence, Italy
- Senior Microbiologist and Head of the Laboratory, Clinical Hospital for Infectious Diseases, Cluj-Napoca; Associated Professor, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania
